Exane Derivatives’s Pentair PNR Stock Holding History
Bought
Maintained
Sold
Other funds holding PNR
PAMS
Exane Derivatives's PNR Position: Q2 2022 in Review
Exane Derivatives reduced its Pentair (PNR) stake by 98% in Q2 2022, selling an estimated $133K and leaving 51 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #424.
Exane Derivatives first reported a position in PNR in Q1 2021 and has held it in 6 quarters since. The position peaked at $336K in Q2 2021. 511 funds tracked by Wall St. Rank hold PNR as of Q2 2022.
- Exane Derivatives held 51 shares of Pentair worth $2.33K as of Q2 2022.
- Exane Derivatives sold 2,666 Pentair shares in Q2 2022, an estimated $133K.
- Pentair made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #424 holding.
- Exane Derivatives first reported a position in Pentair in Q1 2021 and has held it in 6 quarters since.
- Exane Derivatives's Pentair position peaked at $336K in Q2 2021.
- 511 funds tracked by Wall St. Rank held Pentair as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.